Affymax names Karin Walker VP of finance and CAO
This article was originally published in Scrip
Affymax has appointed Karin Walker vice-president of finance and chief accounting officer, reporting to Herb Cross, Affymax's CFO. With over 20 years' experience of financial management, Ms Walker most recently served as vice-president of finance and corporate controller at Amyris.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.